Delivery Order SPE2DB24D1021-SPE2DB25FEWWS

Award Date 5/16/25
Potential Completion Date 5/19/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,332.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,964,091 units of PROVOCHOLINE 100 MG VIALS, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 21, 2025. The contract is not set aside for any specific type of business. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,644.93, is for the delivery of PROVOCHOLINE 100 MG VIALS, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 19, 2024. No set-aside designation was used for this contract award. AmerisourceBergen Drug Corp...
This federal contract award, valued at $9,963.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,873,260 units of PROVOCHOLINE 100 MG VIALS. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of PROVOCHOLINE 100 MG VIALS. The contract has a ceiling value of $3,258.92 and a completion date of September 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of essential medical products to various federal agencies and healthcare programs. This order is part of Amerisourcebergen's...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROVOCHOLINE INHAL SOLN PACK 18ML, a medical product, with a ceiling value of $4,303.46. The contract is a Delivery Order and has a Firm Fixed Price pricing type. The contract has an ultimate completion date of April 1, 2025. This award is not associated with any set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,200.52 firm fixed-price delivery order is for the provision of Provocholine Inhal Soln Pack 18ML, a medical product. The contract has an ultimate completion date of February 25, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,068.26, is a Firm Fixed Price Delivery Order for the supply of Provocholine Inhalation Solution, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,401.04, is for the supply of Provocholine Inhalation Solution, a medical product used in the diagnosis of respiratory disorders. The contract has an ultimate completion date of April 29, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Provocholine Inhal Soln Pack 18ML, a pharmaceutical product, with a firm fixed price of $5,501.30 and a completion date of May 19, 2025. The contract is not set aside and is awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,650.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Provocholine inhalation solution, a medical product used in healthcare settings. The contract has an ultimate completion date of March 28, 2025 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. AmerisourceBergen holds a...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEWWS
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of PROVOCHOLINE 100 MG VIALS, a medical product, with an ultimate completion date of May 19, 2025 and a ceiling value of $2,322.39. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not set aside.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/15/25, 9:58 AM